Serum zinc concentrations and incident hypertension: New findings from a population-based cohort study

Journal of Hypertension

Volumn 34, Issue 6, 2016, Pages 1055-1061

  Kunutsor, Setor K ^a   Laukkanen, Jari A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

blood pressure; cohort; hypertension; risk factor; zinc

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ZINC;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; DIETARY INTAKE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SOCIAL STATUS; ZINC BLOOD LEVEL; BLOOD; DIET; FINLAND; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADULT; DIET; FINLAND; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; ZINC;

EID: 84962092577     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000923     Document Type: Article

References (44)

1. Chimienti F. Zinc, pancreatic islet cell function and diabetes: new insights into an old story. Nutr Res Rev 2013; 26:1-11.
2. Jansen J, Karges W, Rink L. Zinc and diabetes: clinical links and molecular mechanisms. J Nutr Biochem 2009; 20:399-417.
3. Reiterer G, MacDonald R, Browning JD, Morrow J, Matveev SV, Daugherty A, et al. Zinc deficiency increases plasma lipids and atherosclerotic markers in LDL-receptor-deficient mice. J Nutr 2005; 135:2114-2118.
4. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL. Zinc and cardiovascular disease. Nutrition 2010; 26:1050-1057.
5. Reunanen A, Knekt P, Marniemi J, Maki J, Maatela J, Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 1996; 50:431-437.
6. Kok FJ, Van Duijn CM, Hofman A, Van der Voet GB, De Wolff FA, Paays CH, et al. Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Epidemiol 1988; 128:352-359.
7. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 1998; 17:564-570.
8. Tubek S. Role of zinc in regulation of arterial blood pressure and in the etiopathogenesis of arterial hypertension. Biol Trace Elem Res 2007; 117:39-51.
9. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35:776-785.
10. Bergomi M, Rovesti S, Vinceti M, Vivoli R, Caselgrandi E, Vivoli G. Zinc and copper status and blood pressure. J Trace Elem Med Biol 1997; 11:166-169.
11. Harlan WR, Landis JR, Schmouder RL, Goldstein NG, Harlan LC. Blood lead and blood pressure. Relationship in the adolescent and adult US population. JAMA 1985; 253:530-534.
12. Frithz G, Ronquist G. Increased red cell content of Zn2 in essential hypertension. Acta Med Scand 1979; 205:647-649.
13. Davydenko NV, Smirnova IP, Kvasha EA, Gorbas IM, Koblianskaia AV. Interrelationship between dietary intake of minerals and prevalence of hypertension. Vopr Pitan 1995;17-19.
14. Kim J. Dietary zinc intake is inversely associated with systolic blood pressure in young obese women. Nutr Res Pract 2013; 7:380-384.
15. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 1988; 20:46-50.
16. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86:803-811.
17. Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Hypertension 1996; 27:1059-1064.
18. Laukkanen JA, Laaksonen D, Lakka TA, Savonen K, Rauramaa R, Makikallio T, et al. Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol 2009; 103:1598-1604.
19. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 1994; 330:1549-1554.
20. Therneau TM, Grambsch PM. Modeling survival data: extending the cox model. New York, NY: Springer; 2000.
21. Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991; 10:1025-1035.
22. Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a populationbased cohort study. Diabetologia 2015; 58:961-967.
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Inter Med 2009; 150:604-612.
24. Tomat AL, Weisstaub AR, Jauregui A, Pineiro A, Balaszczuk AM, Costa MA, et al. Moderate zinc deficiency influences arterial blood pressure and vascular nitric oxide pathway in growing rats. Pediatr Res 2005; 58:672-676.
25. Sato M, Yanagisawa H, Nojima Y, Tamura J, Wada O. Zn deficiency aggravates hypertension in spontaneously hypertensive rats: possible role of Cu/Zn-superoxide dismutase. Clin Exp Hyper 2002; 24:355-370.
26. Henrotte JG, Santarromana M, Franck G, Bourdon R. Blood and tissue zinc levels in spontaneously hypertensive rats. J Am Coll Nutr 1990; 9:340-343.
27. Henrotte JG, Santarromana M, Franck G, Guicheney P, Boulu R, Bourdon R. High cardiac zinc levels in spontaneously hypertensive rats. J Hypertens 1992; 10:553-559.
28. Hennig B, Wang Y, Ramasamy S, McClain CJ. Zinc deficiency alters barrier function of cultured porcine endothelial cells. J Nutr 1992; 122:1242-1247.
29. Powell SR. The antioxidant properties of zinc.JNutr 2000; 130 (5S Suppl): 1447S-1454S.
30. Ahn BI, Kim MJ, Koo HS, Seo N, Joo NS, Kim YS. Serum zinc concentration is inversely associated with insulin resistance but not related with metabolic syndrome in nondiabetic Korean adults. Biol Trace Elem Res 2014; 160:169-175.
31. Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr 2009; 90:329-335.
32. Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Gender differences in the relationship between serum zinc concentration and metabolic syndrome. Ann Hum Biol 2014; 41:436-442.
33. Yu Y, Cai Z, Zheng J, Chen J, Zhang X, Huang XF, et al. Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are high. Nutr Res 2012; 32:71-77.
34. Yary T, Virtanen JK, Ruusunen A, Tuomainen TP, Voutilainen S. Serum zinc and risk of type 2 diabetes incidence in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. J Trace Elem Med Biol 2016; 33:120-124.
35. Vezzoli G, Elli AA, Tripodi G, Bianchi G, Carafoli E. Calcium ATPase in erythrocytes of spontaneously hypertensive rats of the Milan strain. J Hypertens 1985; 3:645-648.
36. Berridge MJ. Regulation of ion channels by inositol trisphosphate and diacylglycerol. J Exp Biol 1986; 124:323-335.
37. Dahlheim H, White CL, Rothemund J, von Lutterotti N, Jacob IC, Rosenthal J. Effect of zinc depletion on angiotensin I-converting enzyme in arterial walls and plasma of the rat. Miner Electrolyte Metab 1989; 15:125-129.
38. Browning JD, Reeves PG, O'Dell BL. Zinc deficiency in rats reduces the vasodilation response to bradykinin and prostacyclin. J Nutr 1987; 117:490-495.
39. Kurihara N, Yanagisawa H, Sato M, Tien CK, Wada O. Increased renal vascular resistance in zinc-deficient rats: role of nitric oxide and superoxide. Clin Exp Pharmacol Physiol 2002; 29:1096-1104.
40. Yanagisawa H, Miyazaki T, Nodera M, Miyajima Y, Suzuki T, Kido T, et al. Zinc-excess intake causes the deterioration of renal function accompanied by an elevation in systemic blood pressure primarily through superoxide radical-induced oxidative stress. Int J Toxicol 2014; 33:288-296.
41. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006; 20:3-18.
42. Davies IJ, Musa M, Dormandy TL. Measurements of plasma zinc. I. In health and disease. J Clin Pathol 1968; 21:359-363.
43. Pirkle, J.L. Laboratory Procedure Manual. Zinc, Copper and Selenium ICPDRCMS-3006.7. Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/data/nhanes/nhanes-11-12/CUSEZN-G- met-serum-elements.pdf. [Accessed 3 February 2016]
44. Arnaud, J. Stability of serum copper, slenium and zinc. French Trace Element External Quality Assessment Scheme and Thematic Network Organizers of external quality assessment /proficiency testing schemes related to occupational and environmental laboratory medicine. http:// www.trace-elements.eu/secure/DownloadFile.aspx?File=2010%20Sta bility-FESTEM%20(poster).pdf. [Accessed 3 February 2016]